These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1734910)

  • 21. Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles.
    Tan FK; Arnett FC; Reveille JD; Ahn C; Antohi S; Sasaki T; Nishioka K; Bona CA
    Arthritis Rheum; 2000 Nov; 43(11):2464-71. PubMed ID: 11083269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-U3 RNP autoantibodies in systemic sclerosis.
    Aggarwal R; Lucas M; Fertig N; Oddis CV; Medsger TA
    Arthritis Rheum; 2009 Apr; 60(4):1112-8. PubMed ID: 19333934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial variation in clinical and immunological manifestations of systemic sclerosis.
    Nietert PJ; Mitchell HC; Bolster MB; Shaftman SR; Tilley BC; Silver RM
    J Rheumatol; 2006 Feb; 33(2):263-8. PubMed ID: 16465656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
    Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N
    Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis.
    Asano Y; Ihn H; Yamane K; Kubo M; Tamaki K
    J Invest Dermatol; 2003 Feb; 120(2):204-10. PubMed ID: 12542523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.
    Steen VD; Powell DL; Medsger TA
    Arthritis Rheum; 1988 Feb; 31(2):196-203. PubMed ID: 3348823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scleroderma: DR antigens, autoantibodies and clinical manifestations.
    Alarcón GS; McCarty GA; Lanyon P; Phillips RM; Acton RT; Barger BO
    Clin Exp Rheumatol; 1987; 5(4):317-21. PubMed ID: 3326691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients.
    Satoh M; Kuwana M; Ogasawara T; Ajmani AK; Langdon JJ; Kimpel D; Wang J; Reeves WH
    J Immunol; 1994 Dec; 153(12):5838-48. PubMed ID: 7989779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma.
    Sato H; Lagan AL; Alexopoulou C; Vassilakis DA; Ahmad T; Pantelidis P; Veeraraghavan S; Renzoni E; Denton C; Black C; Wells AU; du Bois RM; Welsh KI
    Arthritis Rheum; 2004 Feb; 50(2):558-64. PubMed ID: 14872499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis.
    Arnett FC; Reveille JD; Goldstein R; Pollard KM; Leaird K; Smith EA; Leroy EC; Fritzler MJ
    Arthritis Rheum; 1996 Jul; 39(7):1151-60. PubMed ID: 8670324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and laboratory features of African-Brazilian patients with systemic sclerosis.
    Mendes C; Viana VST; Pasoto SG; Leon EP; Bonfa E; Sampaio-Barros PD
    Clin Rheumatol; 2020 Jan; 39(1):9-17. PubMed ID: 31065858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies in scleroderma: direct pathogenicity and phenotypic associations.
    Chung L; Utz PJ
    Curr Rheumatol Rep; 2004 Apr; 6(2):156-63. PubMed ID: 15016347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis.
    Jacobsen S; Halberg P; Ullman S; Van Venrooij WJ; Høier-Madsen M; Wiik A; Petersen J
    Br J Rheumatol; 1998 Jan; 37(1):39-45. PubMed ID: 9487249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
    Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
    Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
    Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM
    Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study.
    Valenzuela A; Baron M; ; Herrick AL; Proudman S; Stevens W; ; Rodriguez-Reyna TS; Vacca A; Medsger TA; Hinchcliff M; Hsu V; Wu JY; Fiorentino D; Chung L
    Semin Arthritis Rheum; 2016 Dec; 46(3):344-349. PubMed ID: 27371996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetics of systemic sclerosis.
    Reveille JD
    Curr Opin Rheumatol; 1995 Nov; 7(6):522-8. PubMed ID: 8579973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are ACA and Scl 70 antibodies mutually exclusive?
    Jarzabek-Chorzelska M; Błaszczyk M; Kołacińska-Strasz Z; Jabłonska S; Chorzelski T; Maul GG
    Br J Dermatol; 1990 Feb; 122(2):201-8. PubMed ID: 2107867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).
    Reveille JD; Durban E; MacLeod-St Clair MJ; Goldstein R; Moreda R; Altman RD; Arnett FC
    J Clin Invest; 1992 Sep; 90(3):973-80. PubMed ID: 1326003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion.
    Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski T; Jabłońska S; Maul GG
    Arch Dermatol Res; 1990; 282(2):76-83. PubMed ID: 2162156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.